Get the Stockscreener App
10.66
0.56%
-0.06
After Hours:
10.75
0.09
+0.84%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Viatris Inc stock is traded at $10.66, with a volume of 5.99M.
It is down -0.56% in the last 24 hours and up +4.82% over the past month.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
See More
Previous Close:
$10.72
Open:
$10.73
24h Volume:
5.99M
Relative Volume:
0.65
Market Cap:
$12.35B
Revenue:
$14.33B
Net Income/Loss:
$-3.79B
P/E Ratio:
-3.3628
EPS:
-3.17
Net Cash Flow:
$1.84B
1W Performance:
+4.82%
1M Performance:
+4.82%
6M Performance:
+20.59%
1Y Performance:
-16.91%
1-Day Range:
$10.62
$10.88
1-Week Range:
$10.22
$11.28
52-Week Range:
$6.85
$13.55
Viatris Inc Stock (VTRS) Company Profile
Name
Viatris Inc
Sector
Phone
(724) 514-1465
Address
1000 MYLAN BOULEVARD, CANONSBURG
Compare VTRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.66 | 12.35B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
118.80 | 53.24B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.14 | 45.14B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.68 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
UTHR
United Therapeutics Corp
|
471.92 | 20.08B | 3.08B | 1.24B | 1.07B | 25.61 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-25 | Initiated | Truist | Buy |
| Jun-06-25 | Initiated | Goldman | Neutral |
| Jul-19-24 | Resumed | Jefferies | Buy |
| Oct-23-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-23-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-24-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-17-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-27-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-10-22 | Upgrade | UBS | Sell → Neutral |
| Nov-08-22 | Upgrade | Piper Sandler | Underweight → Neutral |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Jun-14-22 | Initiated | UBS | Sell |
| May-10-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Mar-01-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-01-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-15-21 | Initiated | Citigroup | Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Mar-08-21 | Downgrade | Goldman | Buy → Neutral |
| Mar-02-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-21 | Initiated | Argus | Hold |
| Dec-14-20 | Initiated | Bernstein | Mkt Perform |
View All
Viatris Inc Stock (VTRS) Latest News
Will Viatris Inc. (VIA) stock benefit from commodity supercycle2025 Market WrapUp & Safe Capital Preservation Plans - newser.com
Why Viatris Inc. stock could be next big winnerJuly 2025 Reactions & Verified Stock Trade Ideas - newser.com
Is now a turning point for Viatris Inc.July 2025 Setups & Consistent Growth Equity Picks - newser.com
Using AI based signals to follow Viatris Inc.Quarterly Profit Report & Expert Approved Momentum Ideas - newser.com
What technical charts say about Viatris Inc. stockMarket Trend Summary & Daily Stock Trend Reports - newser.com
Is it time to cut losses on Viatris Inc.Earnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com
What dividend safety score for Viatris Inc. stockEarnings Summary Report & Weekly Market Pulse Updates - newser.com
Can volume confirm reversal in Viatris Inc.Quarterly Earnings Summary & Smart Swing Trading Techniques - newser.com
Can Viatris Inc. (VIA) stock surprise markets with earningsJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com
Will Viatris Inc. stock go up soonQuarterly Earnings Report & Free Fast Entry Momentum Trade Alerts - newser.com
What does recent volatility data suggest for Viatris Inc.Portfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com
Is Viatris Inc. stock recession proofJuly 2025 Movers & Real-Time Volume Analysis Alerts - newser.com
Is Viatris Inc. stock a good choice for value investorsJuly 2025 Big Picture & Technical Buy Zone Confirmations - newser.com
Chris Davis's Strategic Acquisition of Viatris Inc. Shares - GuruFocus
Viatris Inc (VTRS)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus
Should I hold or sell Viatris Inc. stock in 2025Weekly Earnings Recap & AI Enhanced Market Trend Forecasts - Fundação Cultural do Pará
Viatris (VTRS): Assessing Valuation After Raised 2025 Guidance and Strong Earnings Signals - Yahoo Finance
Viatris (VTRS) Is Up 7.9% After Boosting 2025 Revenue Outlook and Reaffirming Dividend - simplywall.st
What is the fair value estimate for Viatris Inc. (VIA) stock in 2025Market Performance Report & Reliable Breakout Forecasts - newser.com
Published on: 2025-11-13 16:37:01 - newser.com
How Recent Developments Are Rewriting the Story for Viatris - Yahoo Finance
Viatris Inc. stock outlook for YEARJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Viatris Recognized as One of the Fortune World's Best Workplaces in 2025 - Finviz
Viatris (NASDAQ: VTRS) among 25 on Fortune World's Best Workplaces, from 9M+ responses - Stock Titan
Viatris Recognized as One of the Fortune World's Best Workplacestm in 2025 - Lelezard
Reflecting On Generic Pharmaceuticals Stocks’ Q3 Earnings: Viatris (NASDAQ:VTRS) - Barchart.com
Is Viatris Inc. (VIA) stock overpriced at current multiples2025 Major Catalysts & Reliable Entry Point Trade Alerts - newser.com
Viatris Inc Stock (VTRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
3.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):